MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 73 filers reported holding MONTE ROSA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $16,000 | +77.8% | 4,187 | +248.3% | 0.00% | – |
| Q1 2024 | $9,000 | -85.7% | 1,202 | -89.2% | 0.00% | – |
| Q4 2023 | $63,000 | +75.0% | 11,118 | +50.3% | 0.00% | – |
| Q3 2023 | $36,000 | +44.0% | 7,399 | +100.6% | 0.00% | – |
| Q2 2023 | $25,000 | +47.1% | 3,688 | +68.8% | 0.00% | – |
| Q1 2023 | $17,000 | -56.4% | 2,185 | -58.1% | 0.00% | – |
| Q4 2022 | $39,000 | +457.1% | 5,215 | +514.3% | 0.00% | – |
| Q3 2022 | $7,000 | 0.0% | 849 | +28.2% | 0.00% | – |
| Q2 2022 | $7,000 | -78.1% | 662 | -70.9% | 0.00% | – |
| Q1 2022 | $32,000 | -52.9% | 2,275 | -32.2% | 0.00% | – |
| Q4 2021 | $68,000 | +134.5% | 3,355 | +162.3% | 0.00% | – |
| Q3 2021 | $29,000 | – | 1,279 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $32,804,000 | 6.54% |
| Cormorant Asset Management, LP | 3,102,199 | $67,957,000 | 2.76% |
| NEA Management Company, LLC | 7,703,205 | $171,627,000 | 2.04% |
| Avoro Capital Advisors LLC | 3,311,434 | $61,003,000 | 0.96% |
| Octagon Capital Advisors LP | 150,000 | $3,342,000 | 0.82% |
| Alphabet Inc. | 1,464,015 | $32,618,000 | 0.77% |
| Casdin Capital, LLC | 960,883 | $21,408,000 | 0.53% |
| RTW INVESTMENTS, LP | 1,214,572 | $26,005,000 | 0.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 119,647 | $2,666,000 | 0.22% |
| Avidity Partners Management LP | 300,000 | $6,684,000 | 0.15% |